Rexahn

Rick Soni, President of Rexahn, commented, This clinical milestone represents another important advance in the development of Serdaxin.

Rexahn Pharmaceuticals Enrolls First Patient in Serdaxin® Phase IIb Clinical Trial - Yahoo! Finance 2011

Rexahn currently has three drug candidates in Phase II clinical trials, Archexin

Rexahn Pharmaceuticals Enrolls First Patient in Serdaxin® Phase IIb Clinical Trial - Yahoo! Finance 2011

Rexahn currently has three drug candidates in Phase II clinical trials, Archexin

unknown title 2011

Rexahn undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

unknown title 2011

For Rexahn, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of Rexahn's licensees or sublicensees; the success of clinical testing; and Rexahn's need for and ability to obtain additional financing.

unknown title 2011

Rexahn also operates key R&D programs of nano-medicines, 3D-GOLD, and TIMES drug discovery platforms.

unknown title 2011

More detailed information on these and additional factors that could affect Rexahn's actual results are described in Rexahn's filings with the U.S. Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q.

unknown title 2011

Uncertainties and risks may cause Rexahn's actual results to be materially different than those expressed in or implied by Rexahn's forward-looking statements.

unknown title 2011

Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing and commercializing first in class and market leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs.

unknown title 2011

Rick Soni, President of Rexahn, said, We are very pleased to obtain this new US patent coverage for the neurotherapeutic treatment of sexual dysfunction, especially as we make progress in the development of Zoraxel

unknown title 2011